Publications
34
Citations
479
Est. group size
—
Recurring co-author estimate
Active years
11
Publishing since 2015
Brian Giacopelli's research focuses on blood cancers, especially leukemia, with attention to genetic mutations and epigenetic changes (chemical modifications to DNA that affect gene activity) that drive disease progression. More recent work shifts toward developing blood-based tests (liquid biopsies) that detect cancer DNA fragments circulating in the blood, combining genetic and epigenetic markers for cancer detection, including in lung cancer. This work sits at the intersection of cancer biology and diagnostic technology development.
Publication output has been variable over the past decade, with a gap in 2017 and 2022, a notable peak of 10 papers in 2023, and lower counts in surrounding years, averaging about 2.6 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 3675: An integrated approach for simultaneous detection of genomic and epigenetic alterations in blood-based ctDNA analysis
Cancer Research · 2025
- Abstract 5896: Tissue naive comprehensive methylation profiling enhances the identification of ctDNA in lung cancer
Cancer Research · 2025
- EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
Leukemia · 2016
- Blood×12
- Journal of Hematology & Oncology×2
- Leukemia×2
- Cancer Research×2
- Cancer Discovery×1
- Jae Yoon Jeon
Medicine · The Ohio State University
- Sai Prasad Desikan
Medicine · The Ohio State University
- Ying Huang
Medicine · The Ohio State University
- Timothy L. Chen
Medicine · The Ohio State University
- Yue-Zhong Wu
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile